BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9864199)

  • 1. Localization of the intracellular activity domain of Pasteurella multocida toxin to the N terminus.
    Wilson BA; Ponferrada VG; Vallance JE; Ho M
    Infect Immun; 1999 Jan; 67(1):80-7. PubMed ID: 9864199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization of functional domains of the mitogenic toxin of Pasteurella multocida.
    Pullinger GD; Sowdhamini R; Lax AJ
    Infect Immun; 2001 Dec; 69(12):7839-50. PubMed ID: 11705966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pasteurella multocida toxin activates the inositol triphosphate signaling pathway in Xenopus oocytes via G(q)alpha-coupled phospholipase C-beta1.
    Wilson BA; Zhu X; Ho M; Lu L
    J Biol Chem; 1997 Jan; 272(2):1268-75. PubMed ID: 8995431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substrate specificity of Pasteurella multocida toxin for α subunits of heterotrimeric G proteins.
    Orth JH; Fester I; Siegert P; Weise M; Lanner U; Kamitani S; Tachibana T; Wilson BA; Schlosser A; Horiguchi Y; Aktories K
    FASEB J; 2013 Feb; 27(2):832-42. PubMed ID: 23150526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pasteurella multocida toxin interacts with signalling pathways to perturb cell growth and differentiation.
    Lax AJ; Pullinger GD; Baldwin MR; Harmey D; Grigoriadis AE; Lakey JH
    Int J Med Microbiol; 2004 Apr; 293(7-8):505-12. PubMed ID: 15149025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective potential of an attenuated Pasteurella multocida, which expresses only the N-terminal truncated fragment of P. multocida toxin.
    Seo J; Lee S; Pyo H; Lee J; Kim T
    Can J Vet Res; 2010 Jan; 74(1):25-9. PubMed ID: 20357954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenicity of partial fragments of recombinant Pasteurella multocida toxin.
    Lee J; Woo HJ
    J Microbiol Biotechnol; 2010 Dec; 20(12):1756-63. PubMed ID: 21193834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane interaction of Pasteurella multocida toxin involves sphingomyelin.
    Brothers MC; Ho M; Maharjan R; Clemons NC; Bannai Y; Waites MA; Faulkner MJ; Kuhlenschmidt TB; Kuhlenschmidt MS; Blanke SR; Rienstra CM; Wilson BA
    FEBS J; 2011 Dec; 278(23):4633-48. PubMed ID: 21951695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential modulation and subsequent blockade of mitogenic signaling and cell cycle progression by Pasteurella multocida toxin.
    Wilson BA; Aminova LR; Ponferrada VG; Ho M
    Infect Immun; 2000 Aug; 68(8):4531-8. PubMed ID: 10899852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive expression of Pasteurella multocida toxin.
    Hoskins IC; Lax AJ
    FEMS Microbiol Lett; 1996 Aug; 141(2-3):189-93. PubMed ID: 8768521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characteristics and immunogenicity of the N-terminal and C-terminal recombinants of Pasteurella multocida toxin].
    Tang X; Wu B; Zhao Z; Deng Y; He H; He Q; Chen H
    Wei Sheng Wu Xue Bao; 2008 Feb; 48(2):213-9. PubMed ID: 18438004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the membrane-targeting C1 domain in Pasteurella multocida toxin.
    Kamitani S; Kitadokoro K; Miyazawa M; Toshima H; Fukui A; Abe H; Miyake M; Horiguchi Y
    J Biol Chem; 2010 Aug; 285(33):25467-75. PubMed ID: 20534589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structures reveal a thiol protease-like catalytic triad in the C-terminal region of Pasteurella multocida toxin.
    Kitadokoro K; Kamitani S; Miyazawa M; Hanajima-Ozawa M; Fukui A; Miyake M; Horiguchi Y
    Proc Natl Acad Sci U S A; 2007 Mar; 104(12):5139-44. PubMed ID: 17360394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning and expression of the Pasteurella multocida toxin gene, toxA, in Escherichia coli.
    Petersen SK; Foged NT
    Infect Immun; 1989 Dec; 57(12):3907-13. PubMed ID: 2680987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of Galpha (i) and subsequent uncoupling of receptor-Galpha(i) signaling by Pasteurella multocida toxin.
    Orth JH; Fester I; Preuss I; Agnoletto L; Wilson BA; Aktories K
    J Biol Chem; 2008 Aug; 283(34):23288-94. PubMed ID: 18583341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. His1205 and His1223 are essential for the activity of the mitogenic Pasteurella multocida toxin.
    Orth JH; Blöcker D; Aktories K
    Biochemistry; 2003 May; 42(17):4971-7. PubMed ID: 12718539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arf6-dependent intracellular trafficking of Pasteurella multocida toxin and pH-dependent translocation from late endosomes.
    Repella TL; Ho M; Chong TP; Bannai Y; Wilson BA
    Toxins (Basel); 2011 Mar; 3(3):218-41. PubMed ID: 22053287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological activity of a C-terminal fragment of Pasteurella multocida toxin.
    Busch C; Orth J; Djouder N; Aktories K
    Infect Immun; 2001 Jun; 69(6):3628-34. PubMed ID: 11349023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a toxA gene knock-out mutant of Pasteurella multocida and evaluation of its protective effects.
    Kim TJ; Lee JI; Lee BJ
    J Microbiol; 2006 Jun; 44(3):320-6. PubMed ID: 16820762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Action of Pasteurella multocida toxin depends on the helical domain of Galphaq.
    Orth JH; Lang S; Aktories K
    J Biol Chem; 2004 Aug; 279(33):34150-5. PubMed ID: 15192096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.